These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 11894133)
1. Lack of NQO1 induction in human tumor cells is not due to changes in the promoter region of the gene. Begleiter A; Lange L Int J Oncol; 2002 Apr; 20(4):835-8. PubMed ID: 11894133 [TBL] [Abstract][Full Text] [Related]
2. Involvement of activator protein-1 and nuclear factor-kappaB transcription factors in the control of the DT-diaphorase expression induced by mitomycin C treatment. Yao KS; Hageboutros A; Ford P; O'Dwyer PJ Mol Pharmacol; 1997 Mar; 51(3):422-30. PubMed ID: 9058597 [TBL] [Abstract][Full Text] [Related]
3. NAD(P)H:quinone oxidoreductase1 (DT-diaphorase): expression, regulation, and role in cancer. Joseph P; Xie T; Xu Y; Jaiswal AK Oncol Res; 1994; 6(10-11):525-32. PubMed ID: 7620221 [TBL] [Abstract][Full Text] [Related]
4. Induction of DT-diaphorase in cancer chemoprevention and chemotherapy. Begleiter A; Leith MK; Curphey TJ; Doherty GP Oncol Res; 1997; 9(6-7):371-82. PubMed ID: 9406243 [TBL] [Abstract][Full Text] [Related]
5. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase. Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423 [TBL] [Abstract][Full Text] [Related]
6. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Traver RD; Horikoshi T; Danenberg KD; Stadlbauer TH; Danenberg PV; Ross D; Gibson NW Cancer Res; 1992 Feb; 52(4):797-802. PubMed ID: 1737339 [TBL] [Abstract][Full Text] [Related]
7. An alternatively spliced form of NQO1 (DT-diaphorase) messenger RNA lacking the putative quinone substrate binding site is present in human normal and tumor tissues. Gasdaska PY; Fisher H; Powis G Cancer Res; 1995 Jun; 55(12):2542-7. PubMed ID: 7780966 [TBL] [Abstract][Full Text] [Related]
8. Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase. Wang X; Doherty GP; Leith MK; Curphey TJ; Begleiter A Br J Cancer; 1999 Jun; 80(8):1223-30. PubMed ID: 10376975 [TBL] [Abstract][Full Text] [Related]
9. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent. Winski SL; Hargreaves RH; Butler J; Ross D Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924 [TBL] [Abstract][Full Text] [Related]
10. The NAD(P)H:quinone oxidoreductase locus in human colon carcinoma HCT 116 cells resistant to mitomycin C. Hu LT; Stamberg J; Pan S Cancer Res; 1996 Nov; 56(22):5253-9. PubMed ID: 8912865 [TBL] [Abstract][Full Text] [Related]
12. Cellular kinetics of induction by oltipraz and its keto derivative of detoxication enzymes in human colon adenocarcinoma cells. O'Dwyer PJ; Clayton M; Halbherr T; Myers CB; Yao Ks Clin Cancer Res; 1997 May; 3(5):783-91. PubMed ID: 9815750 [TBL] [Abstract][Full Text] [Related]
13. Alternative splicing and differential expression of DT-diaphorase transcripts in human colon tumors and in peripheral mononuclear cells in response to mitomycin C treatment. Yao KS; Godwin AK; Johnson C; O'Dwyer PJ Cancer Res; 1996 Apr; 56(8):1731-6. PubMed ID: 8620484 [TBL] [Abstract][Full Text] [Related]
14. Effect of NQO1 induction on the antitumor activity of RH1 in human tumors in vitro and in vivo. Digby T; Leith MK; Thliveris JA; Begleiter A Cancer Chemother Pharmacol; 2005 Sep; 56(3):307-16. PubMed ID: 15877230 [TBL] [Abstract][Full Text] [Related]
15. DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell lines. Mikami K; Naito M; Tomida A; Yamada M; Sirakusa T; Tsuruo T Cancer Res; 1996 Jun; 56(12):2823-6. PubMed ID: 8665520 [TBL] [Abstract][Full Text] [Related]
16. Increased tumor necrosis factor-alpha sensitivity of MCF-7 cells transfected with NAD(P)H:quinone reductase. Siemankowski LM; Morreale J; Butts BD; Briehl MM Cancer Res; 2000 Jul; 60(13):3638-44. PubMed ID: 10910079 [TBL] [Abstract][Full Text] [Related]
17. Factors influencing the induction of DT-diaphorase activity by 1,2-dithiole-3-thione in human tumor cell lines. Begleiterabc A; Leith MK; Doherty GP; Digbya TJ; Pan S Biochem Pharmacol; 2001 Apr; 61(8):955-64. PubMed ID: 11286987 [TBL] [Abstract][Full Text] [Related]
18. NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues. Belinsky M; Jaiswal AK Cancer Metastasis Rev; 1993 Jun; 12(2):103-17. PubMed ID: 8375015 [TBL] [Abstract][Full Text] [Related]
19. Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity. Fourie J; Guziec F; Guziec L; Monterrosa C; Fiterman DJ; Begleiter A Cancer Chemother Pharmacol; 2004 Mar; 53(3):191-203. PubMed ID: 14614574 [TBL] [Abstract][Full Text] [Related]
20. Effects of hypoxia on detoxicating enzyme activity and expression in HT29 colon adenocarcinoma cells. O'Dwyer PJ; Yao KS; Ford P; Godwin AK; Clayton M Cancer Res; 1994 Jun; 54(12):3082-7. PubMed ID: 8205521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]